Clinical Trials for Connective tissue disorders

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

• Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
• Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
• Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
• Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Connective tissue disorders is grouped into the following categories:-

• View by trial name
• View by drugs used in Connective tissue disorders clinical trials

Clinical Trials by trial name

The format for each of the following is:

• The name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.
• followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Connective tissue disorders:

• Study of Silicone-Associated Connective Tissue Diseases - This study has been completed (Current: 23 Nov 2006)
• Study of Heritable Connective Tissue Disorders - This study has been completed (Current: 23 Nov 2006)
• Absorption of Corticosteroids in Children With Juvenile Dermatomyositis - This study is currently recruiting patients (Current: 23 Nov 2006) - Methylprednisolone,Prednisolone
• Oral Type I Collagen for Relieving Scleroderma - This study is no longer recruiting patients (Current: 23 Nov 2006) - Bovine type I collagen
• Time To Efficacy and Onset Of Action Of Linezolid - This study has been completed (Current: 23 Nov 2006) - linezolid
• Study and Treatment of Inflammatory Muscle Diseases - This study is currently recruiting patients (Current: 23 Nov 2006)
• Ultraviolet Light Therapy for Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis - This study has been completed (Current: 23 Nov 2006) - relaxin
• Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - collagenase
• Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - gamma-Linolenic acid
• Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006) - cytarabine
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006) - dehydroepiandrosterone
• Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006)
• Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006) - dehydroepiandrosterone
• Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006)
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis - This study has been completed (Current: 23 Nov 2006) - iloprost
• Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006) - dehydroepiandrosterone
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,cyclophosphamide,cyclosporine,filgrastim,methylprednisolone,prednisone
• Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture - This study has been completed (Current: 23 Nov 2006)
• Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006) - estradiol,ethinyl estradiol,medroxyprogesterone,norethindrone
• Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-Thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders - This study is currently recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,cyclophosphamide,filgrastim
• Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome - This study has been completed (Current: 23 Nov 2006) - Cyclophosphamide,filgrastim
• Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - collagenase
• Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,cyclophosphamide
• Study of High-Dose Cyclophosphamide and Anti-Thymocyte Globulin With T-Cell-Depleted Autologous Bone Marrow Rescue in Patients With High-Risk Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,cyclophosphamide,filgrastim
• Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,cyclophosphamide,filgrastim
• Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• 41.8 Degree Centigrade Whole Body Hyperthermia for the Treatment of Rheumatoid Diseases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antifolate Effectiveness in Arthritis - This study has been completed (Current: 23 Nov 2006) - Methotrexate
• Oral Collagen for Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Bovine type II collagen
• Improving Vocational Outcomes in Arthritis - This study has been completed (Current: 23 Nov 2006)
• Patient Education in Rheumatoid Arthritis and Osteoarthritis - This study has been completed (Current: 23 Nov 2006)
• Prevention of Arthritis-Related Work Disability - This study has been completed (Current: 23 Nov 2006)
• Psychoeducational Approach to Improve Health in Lupus - This study has been completed (Current: 23 Nov 2006)
• Safety of Estrogens in Lupus: Hormone Replacement Therapy - This study has been terminated (Current: 23 Nov 2006) - Premarin and Provera
• Safety of Estrogens in Lupus: Birth Control Pills - This study has been completed (Current: 23 Nov 2006) - Ortho-Novum 777
• Serologically Active, Clinically Stable Systemic Lupus Erythematosus - This study is no longer recruiting patients (Current: 23 Nov 2006) - Prednisone
• Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Calcium carbonate
• Blocking Tumor Necrosis Factor in Ankylosing Spondylitis - This study has been completed (Current: 23 Nov 2006) - Anti-Tumor Necrosis Factor
• dnaJ Peptide for Relieving Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - dnaJ peptide
• Evaluation of Salivary Gland Dysfunction - This study is currently recruiting patients (Current: 23 Nov 2006)
• Drug Therapy in Lupus Nephropathy - This study has been completed (Current: 23 Nov 2006)
• Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies - This study has been completed (Current: 23 Nov 2006) - Gamma Globulin
• Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions - This study has been completed (Current: 23 Nov 2006)
• Growth Hormone Therapy in Osteogenesis Imperfecta - This study is currently recruiting patients (Current: 23 Nov 2006) - Humatrope,GRH,Nutropin
• Genetic and Family Studies of Inherited Muscle Diseases - This study has been completed (Current: 23 Nov 2006)
• Study of Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006)
• The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis - This study has been completed (Current: 23 Nov 2006)
• Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status - This study has been completed (Current: 23 Nov 2006)
• Methimazole to Treat Polymyositis and Dermatomyositis - This study has been completed (Current: 23 Nov 2006)
• Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals - This study has been completed (Current: 23 Nov 2006)
• Evaluation and Intervention for the Effects of Osteogenesis Imperfecta - This study is currently recruiting patients (Current: 23 Nov 2006)
• DHEA Treatment for Sjogren's Syndrome - This study has been completed (Current: 23 Nov 2006) - Dehydroepiandrosterone
• Pilot Study of Thalidomide to Treat Sjogren's Syndrome - This study has been completed (Current: 23 Nov 2006) - Thalidomide
• The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• Cyclophosphamide and Fludarabine to Treat Lupus Nephritis - This study has been completed (Current: 23 Nov 2006) - SQ Fludarabine
• Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy - This study has been completed (Current: 23 Nov 2006)
• Genetics of Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients - This study has been completed (Current: 23 Nov 2006)
• A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006)
• Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops - This study has been completed (Current: 23 Nov 2006)
• BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis - This study has been completed (Current: 23 Nov 2006)
• Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome - This study is currently recruiting patients (Current: 23 Nov 2006)
• TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Enbrel
• Lung Disease Associated With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers - This study has been completed (Current: 23 Nov 2006)
• Etanercept Therapy for Sjogren's Syndrome - This study has been completed (Current: 23 Nov 2006)
• Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome - This study has been completed (Current: 23 Nov 2006)
• Immune System Related Kidney Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis - This study has been completed (Current: 23 Nov 2006) - olsalazine
• Study of Homocysteine Metabolism in Homocystinuria - This study has been completed (Current: 23 Nov 2006)
• Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into Lymphocytes of Patients With Mucopolysaccharidosis II (Mild Hunter Syndrome) - This study has been completed (Current: 23 Nov 2006)
• Scleroderma Lung Study - This study has been completed (Current: 23 Nov 2006) - cyclophosphamide,azathioprine
• Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency - This study has been terminated (Current: 23 Nov 2006)
• Alpha1-Antitrypsin Deficiency Registry - This study has been completed (Current: 23 Nov 2006)
• Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases - This study has been completed (Current: 23 Nov 2006)
• Lupus Cohort--Thrombotic Events and Coronary Artery Disease - This study has been completed (Current: 23 Nov 2006)
• Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis - This study has been completed (Current: 23 Nov 2006) - h5G1.1-mAb
• High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide - This study is no longer recruiting patients (Current: 23 Nov 2006) - High-dose immunoablative therapy
• Phase II Study of Allogeneic Bone Marrow or Umbilical Cord Blood Transplantation in Patients With Mucopolysaccharidosis I (Hurler Disease) - This study is currently recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,busulfan,cyclophosphamide,cyclosporine,filgrastim,methylprednisolone
• Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Pamidronate to Treat Osteogenesis Imperfecta in Children - This study is currently recruiting patients (Current: 23 Nov 2006) - Pamidronate (Aredia)
• Infliximab for the Treatment of Early Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Infliximab
• Psychological Treatments for Scleroderma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Genetic Analysis of Familial Keloids - This study is currently recruiting patients (Current: 23 Nov 2006)
• Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - cyclophosphamide,filgrastim
• Humanized LL2IGG to Treat Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006) - hLL2 (Epratuzumab)
• The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - TNFR:Fc
• Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients - This study has been completed (Current: 23 Nov 2006) - 15-O labeled water
• ENBREL(R) (Etanercept) Safety Study in Children With Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - ENBREL(R) (etanercept)
• Myositis in Children - This study is currently recruiting patients (Current: 23 Nov 2006)
• Impact of Literacy Level on Patient Education and Health Among People With Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells - This study has been completed (Current: 23 Nov 2006)
• Natural History of Rheumatic Diseases in Minority Communities - This study is currently recruiting patients (Current: 23 Nov 2006)
• Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome - This study has been completed (Current: 23 Nov 2006) - Ophthalmic Emulsion
• Blood Component Collection From Patients With Rheumatic Disease and Healthy Volunteers - This study is currently recruiting patients (Current: 23 Nov 2006)
• Infliximab (Remicade (Registered Trademark)) to Treat Dermatomyositis and Polymyositis - This study is currently recruiting patients (Current: 23 Nov 2006) - Infliximab
• The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept - This study has been completed (Current: 23 Nov 2006) - Etanercept
• Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis. - This study has been completed (Current: 23 Nov 2006) - efalizumab
• Meloxicam Suspension in Juvenile Rheumatoid Arthritis (JRA) - This study has been completed (Current: 23 Nov 2006) - Meloxicam
• Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease - This study has been completed (Current: 23 Nov 2006) - Abetimus sodium (LJP 394)
• Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis - This study has been completed (Current: 23 Nov 2006) - NC-503 (Anti-amyloidotic (AA) Agent)
• Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis - This study has been terminated (Current: 23 Nov 2006) - Prednisone,Methotrexate,Etanercept
• Study to Assess Efficacy of Tacrolimus + Methotrexate Vs. Placebo + Methotrexate in Treatment of Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Tacrolimus (Prograf®),Methotrexate
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Infliximab
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Infliximab
• Anti-CD20 in Systemic Lupus Erythematosus - This study is no longer recruiting patients (Current: 23 Nov 2006) - Rituximab
• Study of GL701 in Men With Systemic Lupus Erythematosus - This study is no longer recruiting patients (Current: 23 Nov 2006) - GL701
• Atherosclerosis in Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Anakinra
• Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - anakinra,pegsunercept
• A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate - This study has been terminated (Current: 23 Nov 2006) - AMG 719
• Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients - This study has been suspended (Current: 23 Nov 2006) - Fludarabine,Cyclophosphamide,Thymoglobulin
• A Trial to Compare the Efficacy and Safety of Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Meloxicam
• Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-Alpha Blocker - This study has been completed (Current: 23 Nov 2006) - HuMax-CD4
• Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006)
• Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis - This study has been completed (Current: 23 Nov 2006) - Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody
• Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate - This study is no longer recruiting patients (Current: 23 Nov 2006) - Scio-469
• Monoclonal Antibody Treatment for Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006) - MRA
• ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - ISIS 104838
• Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Adalimumab/anti-TNF alfa
• A Phase III Study of BMS-188667 in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate - This study is no longer recruiting patients (Current: 23 Nov 2006) - BMS-188667
• Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. - This study has been completed (Current: 23 Nov 2006) - BMS-188667
• Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI - This study is no longer recruiting patients (Current: 23 Nov 2006) - N-acetylgalactosamine 4-sulfatase
• Open-Label Study of Efficacy and Safety of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI - This study is no longer recruiting patients (Current: 23 Nov 2006) - N-acetylgalactosamine 4-sulfatase
• A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - BMS-188667
• Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Adalimumab (D2E7)
• Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) - This study is no longer recruiting patients (Current: 23 Nov 2006) - pravastatin,aspirin,ramipril,Vitamins: B6, B12, and folate
• Study of Families With Twins or Siblings Discordant for Rheumatic Disorders - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Phase 2 Open-Label Clinical Study Using Intravenous Paxceed to Treat Patients With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Micellar Paclitaxel for Injection
• Coping Skills Training for Early Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Clinically Important Changes in Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Relaxation Response Training for the Treatment of Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study - This study is currently recruiting patients (Current: 23 Nov 2006)
• Genetic Determinants of Ankylosing Spondylitis Severity - This study is currently recruiting patients (Current: 23 Nov 2006)
• Stem Cell Transplant to Treat Patients With Systemic Sclerosis - This study has been completed (Current: 23 Nov 2006) - Cyclophosphamide,Mesna,G-CSF
• Phase 2 Trial of TD 6424 Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections - This study has been completed (Current: 23 Nov 2006) - TD-6424
• Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine - This study has been completed (Current: 23 Nov 2006) - TwHF
• Bisphosphonate Treatment of Osteogenesis Imperfecta - This study is currently recruiting patients (Current: 23 Nov 2006) - Zoledronic Acid
• Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) - This study is currently recruiting patients (Current: 23 Nov 2006) - Atorvastatin
• Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase (rhASB) in Patients With MPS VI - This study has been completed (Current: 23 Nov 2006) - N-acetylgalactosamine 4-sulfatase
• 4-PBA: Will It Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency? - This study is no longer recruiting patients (Current: 23 Nov 2006) - 4 Phenyl Butyrate (4PBA)
• Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate - This study is no longer recruiting patients (Current: 23 Nov 2006) - MEDI-522
• Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases - This study is currently recruiting patients (Current: 23 Nov 2006)
• Genetic Registry for Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Iduronate-2-Sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II) - This study is no longer recruiting patients (Current: 23 Nov 2006) - Iduronate-2-sulfatase enzyme replacement therapy
• Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma - This study is no longer recruiting patients (Current: 23 Nov 2006) - Bosentan
• Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• Genetic Studies of Lupus - This study is currently recruiting patients (Current: 23 Nov 2006)
• Meditation-Based Stress Reduction in Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• Study of LymphoStat-B in Subjects With Systemic Lupus Erythematosus (SLE) - This study is no longer recruiting patients (Current: 23 Nov 2006) - belimumab (LymphoStat-B)
• Study of LymphoStat-B (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - belimumab (LymphoStat-B)
• Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Treatment of Rheumatoid Arthritis With Marine and Botanical Oils - This study is currently recruiting patients (Current: 23 Nov 2006) - fish oil,borage seed oil,combination fish oil and borage seed oil
• The Research Registry for Neonatal Lupus - This study is currently recruiting patients (Current: 23 Nov 2006)
• Efficacy and Safety Study of Rituximab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - rituximab
• Registry for African Americans With Early Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• Scleroderma Registry - This study is currently recruiting patients (Current: 23 Nov 2006)
• Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy - This study has been terminated (Current: 23 Nov 2006) - CCI-779
• Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006) - Isolex/Rituximab
• Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients - This study has been completed (Current: 23 Nov 2006) - Bosentan
• A Safety Study of Escalating Doses of PRO70769 for Subjects With Moderate to Severe Rheumatoid Arthritis Receiving Stable Doses of Concomitant Methotrexate - This study is no longer recruiting patients (Current: 23 Nov 2006) - PRO70769 (rhuMAb 2H7)
• Registry of Etanercept (Enbrel) In Children With Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Enbrel®
• Safety and Efficacy Study of Etanercept (Enbrel) In Children With Systemic Onset Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Enbrel®
• Genetics of Ankylosing Spondylitis - This study is currently recruiting patients (Current: 23 Nov 2006)
• GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids - This study is no longer recruiting patients (Current: 23 Nov 2006) - Prasterone (GL701)
• Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate - This study has been completed (Current: 23 Nov 2006) - Natalizumab
• Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Adalimumab (D2E7)
• Progression of Spinal Fusion in Ankylosing Spondylitis - This study is currently recruiting patients (Current: 23 Nov 2006)
• New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus - This study is currently recruiting patients (Current: 23 Nov 2006) - Triptorelin
• Pain and Stress Management for People With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Study of LJP 394 in Lupus Patients With History of Renal Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - abetimus sodium (LJP 394)
• SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate - This study is no longer recruiting patients (Current: 23 Nov 2006) - SCIO-469
• Juvenile Rheumatoid Arthritis Research Registry - This study is currently recruiting patients (Current: 23 Nov 2006)
• Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - MK0663, etoricoxib,Comparator: Diclofenac sodium
• Preference of Rheumatoid Arthritis (RA) Patients of Enbrel (Etanercept) Auto-Injector Versus Enbrel Pre-Filled Syringes - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
• Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) - This study is no longer recruiting patients (Current: 23 Nov 2006) - CTLA4-IgG4m (RG2077)
• OPPOSITE: Open-Label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After an Incomplete Response To Etanercept - This study has been completed (Current: 23 Nov 2006) - Infliximab,Etanercept
• A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss - This study is currently recruiting patients (Current: 23 Nov 2006) - Fish oil supplement
• Internleukin-1 Trap to Treat Autoinflammatory Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - IL-1 Trap
• Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Abatacept or Infliximab with Methotrexate
• BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Abatacept
• Study Evaluating TMI-005 in Active Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - TMI-005
• Efficacy, Safety and Tolerability of AMG 162 in the Treatment of Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - AMG 162
• Comparing Tai Chi Chih and Relaxation Therapy in the Treatment of Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Effectiveness and Safety of Enbrel (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade (Infliximab) - This study is currently recruiting patients (Current: 23 Nov 2006) - Etanercept
• Anti-CD20 Antibody Therapy for Sjogren's Syndrome - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• Study of rhASB in Patients With Mucopolysaccharidosis VI - This study is no longer recruiting patients (Current: 23 Nov 2006) - N-acetylgalactosamine 4-sulfatase
• Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MM-093
• Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children - This study is currently recruiting patients (Current: 23 Nov 2006) - risedronate sodium (Actonel)
• Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy - This study is currently recruiting patients (Current: 23 Nov 2006) - tocilizumab [Actemra]
• A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - tocilizumab [Actemra]
• A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - tocilizumab [Actemra]
• A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - tocilizumab [Actemra]
• A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - tocilizumab [Actemra]
• Effects of Pulsed Magnetic Pads on Rheumatoid Arthritis Symptoms in Postmenopausal Women - This study is currently recruiting patients (Current: 23 Nov 2006)
• Treatment for Subjects With Active Rheumatoid Arthritis (RA) - This study has been completed (Current: 23 Nov 2006) - Etanercept Liquid
• Study of Epratuzumab in Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006) - epratuzumab
• Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA) - This study has been completed (Current: 23 Nov 2006) - Anakinra (r-metHuIL-1ra)
• Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA) - This study has been completed (Current: 23 Nov 2006) - Pegsunercept (PEG sTNF-RI)
• A Pilot Study of Etanercept in Dermatomyositis - This study is currently recruiting patients (Current: 23 Nov 2006) - Etanercept
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - GW406381
• Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) - This study is currently recruiting patients (Current: 23 Nov 2006) - epratuzumab
• Scleroderma: Cyclophosphamide or Transplantation (SCOT) - This study is currently recruiting patients (Current: 23 Nov 2006) - High-dose immunosuppressive therapy (HDIT),Cyclosphosphamide,Equine antithymocyte globulin,Methylprednisolone,Growth colony stimulating factor (G-CSF)
• Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW) - This study is currently recruiting patients (Current: 23 Nov 2006) - Etanercept
• Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug (DMARD) Intervention and UtilizationStudy - This study is no longer recruiting patients (Current: 23 Nov 2006) - DMARD
• Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug (DMARD) Intervention and UtilizationStudy - This study is no longer recruiting patients (Current: 23 Nov 2006) - ENBREL®
• Anakinra (Kineret) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA) - This study has been completed (Current: 23 Nov 2006) - Anakinra (Kineret®)
• Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone - This study is currently recruiting patients (Current: 23 Nov 2006) - Abatacept, Prednisone or Prednisone equivalent
• Lupus Atherosclerosis Prevention Study - This study has been completed (Current: 23 Nov 2006) - Atorvastatin
• Evaluating Kineret (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire - This study has been completed (Current: 23 Nov 2006) - Kineret® (Anakinra)
• REKinDLE: Registry With Enbrel or Kineret in a Database Using Longitudinal Evaluations - This study is no longer recruiting patients (Current: 23 Nov 2006) - Enbrel®,Kineret®
• Aspreva Lupus Management Study (ALMS) - This study is currently recruiting patients (Current: 23 Nov 2006) - Mycophenolate mofetil,Intravenous cyclophosphamide (active comparator, induction),Azathioprine (active comparator, maintenance)
• Remission in Early Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Abatacept
• Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Epoetin alfa
• Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand - This study is currently recruiting patients (Current: 23 Nov 2006)
• Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients - This study is no longer recruiting patients (Current: 23 Nov 2006) - Abatacept
• Triptorelin for Ovary Protection in Childhood Onset Lupus - This study is currently recruiting patients (Current: 23 Nov 2006) - Triptorelin pamoate (Trelstar Depot)
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-Biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy - This study is currently recruiting patients (Current: 23 Nov 2006) - Abatacept
• Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis - This study is currently recruiting patients (Current: 23 Nov 2006) - tacrolimus
• Study of Intra-Articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects - This study is currently recruiting patients (Current: 23 Nov 2006)
• Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix - This study is currently recruiting patients (Current: 23 Nov 2006)
• Human Anti-Tac (Daclizumab) to Treat JIA-Associated Uveitis - This study is currently recruiting patients (Current: 23 Nov 2006) - HAT,Daclizumab
• Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta - This study is currently recruiting patients (Current: 23 Nov 2006) - Zoledronic Acid
• Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta - This study is currently recruiting patients (Current: 23 Nov 2006) - Teriparatide (FORTEO)
• Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders - This study has been completed (Current: 23 Nov 2006) - Enbrel
• A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients - This study is no longer recruiting patients (Current: 23 Nov 2006) - MK-0873
• TNFalfa Blocking Treatment of Spondylarthropathies - This study is currently recruiting patients (Current: 23 Nov 2006) - Infliximab,Etanercept,Adalimumab
• A Study To Look At the Effects Of A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is An Indicator For Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Prednisolone,SB-681323
• A Study to Evaluate the Efficacy and Safety of Rituximab in Patients With Severe Systemic Lupus Erythematosus (SLE) - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. - This study has been completed (Current: 23 Nov 2006) - Alendronate versus alfacalcidol (1-alpha OH vitamin D)
• Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area - This study has been completed (Current: 23 Nov 2006) - antimicrobial agent in soap
• Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Celecoxib,Diclofenac plus Omeprazole
• Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Methotrexate plus ERB-041 for 12 weeks,Placebo for 12 weeks
• A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects. - This study is no longer recruiting patients (Current: 23 Nov 2006) - AD 452
• Effect of Pulse Width on Scar Treatment Using a 595-Nm Pulsed Dye Laser - This study has been completed (Current: 23 Nov 2006)
• Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Long-Term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Long-Term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Long-Term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Long-Term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Long-Term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Study of MRA in Patients With Rheumatoid Arthritis (RA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• A Phase 4 Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG Levels in Aldurazyme (Laronidase) Treated Patients. - This study is currently recruiting patients (Current: 23 Nov 2006) - Recombinant Human Alpha-L-Iduronidase, Aldurazyme® (laronidase)
• A Dose-Optimization Study of Aldurazyme (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
• Mucopolysaccharidosis I (MPS I) Registry - This study is currently recruiting patients (Current: 23 Nov 2006)
• Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen - This study has been completed (Current: 23 Nov 2006) - Ibuprofen
• Health Benefits of an Exercise Program for Adults With Arthritis - This study has been completed (Current: 23 Nov 2006)
• Prednisone Timed-Release Tablet (TRT) Study: TRT Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Prednisone
• Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients - This study is no longer recruiting patients (Current: 23 Nov 2006) - Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
• Comparison Of 3 Dose Levels Of CP-690,550 VS. Placebo For Treatment Of Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - CP-690,550
• Imiquimod in Children With Plaque Morphea - This study is currently recruiting patients (Current: 23 Nov 2006) - Imiquimod
• Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study) - This study is currently recruiting patients (Current: 23 Nov 2006) - arthroscopic biopsy
• A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Certolizumab pegol (CDP870)
• Physical Therapy for Systemic Lupus Erythematosus (SLE) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Program Evaluation of People With Arthritis Can Exercise - This study has been completed (Current: 23 Nov 2006)
• A Study of Imatinib 400 Mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis. - This study is no longer recruiting patients (Current: 23 Nov 2006) - Imatinib in combination with methotrexate
• Develop Biomarkers for Assessing RA Joint Erosion - This study is currently recruiting patients (Current: 23 Nov 2006)
• Skin Denervation in Systemic Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006)
• Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency - This study has been completed (Current: 23 Nov 2006) - Aerosolized, Recombinant Alpha 1-Antitrypsin
• A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - MK0966; rofecoxib,Comparator: naproxen tablet 500 mg
• Bisphosphonate Therapy for Osteogenesis Imperfecta - This study is currently recruiting patients (Current: 23 Nov 2006) - Alendronate,Pamidronate
• A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Certolizumab Pegol
• A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Certolizumab Pegol
• Open Label Long-Term Safety Study of CDP870 (Certolizumab Pegol) for Patients With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - certolizumab pegol (CDP870)
• Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency - This study has been completed (Current: 23 Nov 2006) - Aerosolized, Recombinant Alpha 1-Antitrypsin
• An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy - This study is no longer recruiting patients (Current: 23 Nov 2006) - Abatacept
• CTLA4IG With Methotrexate- Phase IIB - Long Term - This study is no longer recruiting patients (Current: 23 Nov 2006) - Abatacept
• The Study of Abatacept in Combination With Etanercept - This study is no longer recruiting patients (Current: 23 Nov 2006) - Abatacept
• Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background - This study is currently recruiting patients (Current: 23 Nov 2006) - BMS-582949 and Methotrexate
• 6 Week Open-Label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Lumiracoxib
• Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Certolizumab pegol (CDP870)
• Stem Cell Transplant w/Laronidase for Hurler - This study is currently recruiting patients (Current: 23 Nov 2006) - Laronidase ERT
• Stem Cell Transplantation for Hurler - This study is currently recruiting patients (Current: 23 Nov 2006) - Busulfan,Cyclophosphamide,ATG
• Rheumatic Diseases and Computer Use - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Memantine in Systemic Lupus Erythematosus - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Memantine
• Assessing the Suitability of an Imaging Probe for Use in Clinical Gene Therapy Trials in Cancer and Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study - This study is currently recruiting patients (Current: 23 Nov 2006)
• Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - quinipril
• HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006)
• Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention - This study is currently recruiting patients (Current: 23 Nov 2006) - Dehydroepiandrosterone (DHEA)
• Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type - This study is currently recruiting patients (Current: 23 Nov 2006) - celiprolol
• Study Evaluating Enbrel in Adults With Active Rheumatoid Arthritis in Luxemburg - This study is currently recruiting patients (Current: 23 Nov 2006) - Enbrel
• Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
• Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
• Study Investigating Enbrel for Post-Marketing Surveillance - This study is currently recruiting patients (Current: 23 Nov 2006) - Enbrel
• Study Investigating Enbrel Treatment for Ankylosing Spondylitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Enbrel
• Study Comparing Etanercept and Methotrexate Vs. Methotrexate Alone in Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Etanercept; Methotrexate
• Long Term Open Label Continuation Study - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab (up to 5 years exposure)
• Efficacy, Safety, Immunogenicity and Effect on Immune Response of Adalimumab Following Subcutaneous Administration in Patients With Active RA Treated Concomitantly With MTX. - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab
• Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Adalimumab
• Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) - This study is currently recruiting patients (Current: 23 Nov 2006)
• The Effects of Infliximab in Korean Patients With Active Rheumatoid Arthritis Despite Methotrexate Treatment (Study P04280)(COMPLETED) - This study is no longer recruiting patients (Current: 23 Nov 2006) - infliximab
• A Study of the Effectiveness of Low-Dose Infliximab for Treatment of Ankylosing Spondylitis (Study P04352) - This study is currently recruiting patients (Current: 23 Nov 2006) - infliximab
• A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus - This study is currently recruiting patients (Current: 23 Nov 2006) - edratide
• Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis. - This study is currently recruiting patients (Current: 23 Nov 2006) - Mycophenolate mofetil
• Comparison of Esophageal and Anorectal Manometry Catheters - This study is currently recruiting patients (Current: 23 Nov 2006)
• Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 - This study is no longer recruiting patients (Current: 23 Nov 2006) - VX-702
• A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis. - This study is no longer recruiting patients (Current: 23 Nov 2006) - infliximab
• A Study Evaluating Safety and Efficacy of CNTO 148 Subcutaneous Injection Compared With Placebo in Subjects With Active Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - golimumab,infliximab
• Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Methotrexate,Intraarticular betamethasone,Cyclosporine/placebo-cyclosporine
• Autologous Chondrocyte Implantation in the Patellofemoral Joint - This study has been completed (Current: 23 Nov 2006)
• PEAK Study (Physical Exercise and Activity in Kids) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-Year Manometric Follow-Up - This study has been completed (Current: 23 Nov 2006)
• Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls - This study is currently recruiting patients (Current: 23 Nov 2006)
• Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Response to anakinra associated with methotrexate
• Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - response to infliximab associated with methotrexate
• myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies - This study is currently recruiting patients (Current: 23 Nov 2006)
• MPS VI Clinical Surveillance Program (CSP) - This study is currently recruiting patients (Current: 23 Nov 2006) - galsulfase
• Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I - This study is currently recruiting patients (Current: 23 Nov 2006) - laronidase
• Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis. - This study is currently recruiting patients (Current: 23 Nov 2006) - Infliximab,Adalimumab
• Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Methoxsalen
• The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists - This study is currently recruiting patients (Current: 23 Nov 2006) - TNF-alpha antagonists
• Treatment of Early Systemic Sclerosis by Bosentan - This study is currently recruiting patients (Current: 23 Nov 2006) - bosentan
• Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Medical In-Patient Rehabilitation in Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Rabbit anti-thymocyte globulin,Methylprednisolone,Growth colony stimulating factor (G-CSF),Corticosteroids,Mycophenolate mofetil,Azathioprine,Intravenous immunoglobulin,Methotrexate,Rituximab,Leflunomide
• Imiquimod 5% Cream in Plaque-Type Morphea: A Pilot, Prospective Open-Label Study - This study is currently recruiting patients (Current: 23 Nov 2006) - imiquimod 5% cream (Aldara)
• Exploratory Study for Dry Mouth in Patients With Sjgrens Syndrome - This study is no longer recruiting patients (Current: 23 Nov 2006) - Rebamipide
• Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - adalimumab (up to 9 months exposure),methotrexate
• A Long Term Roll-Over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-Term to Patients With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab
• Predictors of the Response to Etanercept and Adalimumab in Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Biologics
• Adalimumab in Combination With Methotrexate Vs Methotrexate Alone in Early Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab,methotrexate
• Post-Marketing Observational Study in Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab
• Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab
• Quality of Life Study With Adalimumab in Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Adalimumab,Methotrexate
• D2E7-Early AS - This study is no longer recruiting patients (Current: 23 Nov 2006) - Adalimumab 40 mg sc every other week
• Genetic Study of Lupus Patients and Their Families - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab
• Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab,methotrexate
• Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab
• A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Infliximab
• Randomized, Double-Blind, Placebo-Controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT - This study is no longer recruiting patients (Current: 23 Nov 2006) - Epoetin alfa
• Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis - This study is currently recruiting patients (Current: 23 Nov 2006) - infliximab
• A Randomized, Open-Labelled Study to Compare the Efficacy and Safety of Meloxicam 15 Mg IM Ampoules Once Daily and Meloxicam 15 Mg Tablets Administered Orally Once Daily Over a Period of 7 Days in Patients With RA - This study has been completed (Current: 23 Nov 2006) - Meloxicam ampoule,Meloxicam tablet
• Long-Term Observation of Patients With Early Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Rapamycin Vs Methotrexate in Diffuse SSc - This study is no longer recruiting patients (Current: 23 Nov 2006) - rapamycin,methotrexate
• Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - long-circulating liposomal prednisolone
• Pharmacokinetic Study of Aralast (Human Alpha1- PI) - This study is no longer recruiting patients (Current: 23 Nov 2006) - ARALAST Fraction IV-1 Alpha1-Proteinase Inhibitor (ARALAST Fr. IV-1)
• A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate - This study is no longer recruiting patients (Current: 23 Nov 2006) - rituximab
• Methotrexate in Ankylosing Spondylitis (MTX in AS) - This study is no longer recruiting patients (Current: 23 Nov 2006) - Methotrexate
• Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - intraarticular morphine,intraarticular dexamethasone
• Prednisolone in Active Ankylosing Spondylitis (AS) - This study is currently recruiting patients (Current: 23 Nov 2006) - Prednisolon
• Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy - This study has been completed (Current: 23 Nov 2006) - Methotrexate plus ENBREL or ENBREL alone
• Study Evaluating Enbrel in Patients With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Enbrel
• The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol - This study is no longer recruiting patients (Current: 23 Nov 2006) - infliximab
• ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain. - This study is no longer recruiting patients (Current: 23 Nov 2006) - tramadol hydrochloride + acetaminophen
• Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis - This study is currently recruiting patients (Current: 23 Nov 2006) - etanercept,sulphasalazine
• Physical Activity Management for Clients With Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Enbrel Liquid Immunogenicity Protocol - This study is currently recruiting patients (Current: 23 Nov 2006) - Enbrel liquid
• Objectives Study in Rheumatoid Arthritis (The OSRA Study) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects - This study has been completed (Current: 23 Nov 2006) - Etanercept,Methotrexate
• Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA - This study is currently recruiting patients (Current: 23 Nov 2006) - Abatacept
• Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA) - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - GW856553
• A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin - This study is no longer recruiting patients (Current: 23 Nov 2006) - levofloxacin
• A Safety Study of Aldurazyme (JC0498 Laronidase) Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Recombinant Human Alpha-L-Iduronidase, Aldurazyme® (laronidase)
• Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) - This study is currently recruiting patients (Current: 23 Nov 2006) - methotrexate,sulfasalazine,hydroxychloroquine,etanercept
• Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis - This study is currently recruiting patients (Current: 23 Nov 2006) - Alendronate
• Collagenase in the Treatment of Cellulite - This study is currently recruiting patients (Current: 23 Nov 2006) - Collagenase
• A Long Term Safety Study of Infliximab (Remicade) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients - This study is no longer recruiting patients (Current: 23 Nov 2006) - Alpha-1-Proteinase Inhibitor (Human)
• Rheumatoid Arthritis Dose Ranging Study - This study is currently recruiting patients (Current: 23 Nov 2006) - MK-0663, etoricoxib / Duration of Treatment -12 weeks,Comparator: placebo / Duration of Treatment - 12 weeks
• A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-Naive - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - golimumab (CNTO 148)
• A Study of the Safety and Efficacy of Golimumab in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - golimumab (CNTO 148)
• A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Golimumab (CNTO 148)
• A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone - This study has been completed (Current: 23 Nov 2006) - leflunomide combined with prednisone
• Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Infliximab
• Manifestations of Heritable Disorders of Connective Tissue - This study is currently recruiting patients (Current: 23 Nov 2006)
• Hematopoietic Stem Cell Support in Patients With Lupus Erythematosus - This study has been completed (Current: 23 Nov 2006)
• Ramipril in Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Ramipril
• Study Evaluating Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - etanercept
• Meloxicam [Mobic] Suspension in Juvenile Rheumatoid Arthritis (JRA) - This study has been completed (Current: 23 Nov 2006) - meloxicam oral suspension,naproxen oral suspension
• Role of DcR3 in T Cell Activation in SLE and RA - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006)
• Stem Cell Support in Patients With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006)
• Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Vitamin D
• Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers - This study has been completed (Current: 23 Nov 2006) - Abatacept
• A One Year Double-Blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in JRA/JIA - This study has been completed (Current: 23 Nov 2006) - meloxicam 0.25 mg/kg,meloxicam 0.125 mg/kg,naproxen 10 mg/kg
• Phase I/II Multiple-Dose LEA29Y Vs CTLAG4Ig Vs Placebo in Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Belatacept,Abatacept
• Health-Related Quality of Life Measure in Pediatric Lupus - This study is currently recruiting patients (Current: 23 Nov 2006)
• Leflunomide in Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Leflunomide
• Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - CF101
• A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Fontolizumab
• A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With ISN/RPS Class III or IV Lupus Nephritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Pilot Study of Etanercept in Dermatomyositis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - etanercept
• RAHelp.Org: An Online Self Management Program for Adults With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Quality of Sleep in Patients With Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - diazepam,melatonin
• Randomized Fixed Bearing Vs Mobile Bearing Cruciate Retaining TKA - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Gamma Vacuum Foil (GVF) Versus Cross-Linked Polyethylene in Total Knee Arthroplasty Study - This study is currently recruiting patients (Current: 23 Nov 2006)
• An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers - This study has been completed (Current: 23 Nov 2006) - Mupirocin (drug)
• Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Adalimumab,Methotrexate
• Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - BG9924
• Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis - This study has been completed (Current: 23 Nov 2006) - Rituximab
• A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - AMG 108
• The Comparison of the Pharmacokinetic, Safety and Tolerability of Alpha-1 MP and Prolastin in Adult alpha1-Antitrypsin Deficient Patients. - This study is currently recruiting patients (Current: 23 Nov 2006) - alpha-1 proteinase inhibitor (human)
• Study Comparing CUBICIN (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas - This study is currently recruiting patients (Current: 23 Nov 2006) - Daptomycin,Vancomycin
• Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114 - This study is currently recruiting patients (Current: 23 Nov 2006) - SMP-114
• Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil - This study is currently recruiting patients (Current: 23 Nov 2006) - Modafinil
• Methotrexate in the Treatment of Axial Spondyloarthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Methotrexate
• Safety and Tolerability of Rituxan With Methotrexate and Etanercept in Patients With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• Study to Assess the Efficacy and Safety of FK506 Combined With MMF in Lupus Nephritis (III/IV/V) - This study is currently recruiting patients (Current: 23 Nov 2006) - FK506 and MMF(drug)
• A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI - This study is currently recruiting patients (Current: 23 Nov 2006) - galsulfase
• A Study to Evaluate Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s) - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - golimumab (CNTO 148)
• The Safety and Tolerability of Alpha-1 MP in Subjects With Alpha-1-Antitrypsin (AAT) Deficiency. - This study is currently recruiting patients (Current: 23 Nov 2006) - alpha-1 proteinase inhibitor (human)
• To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN - This study has been completed (Current: 23 Nov 2006) - FK506 (Tacrolimus)
• Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Lovastatin
• A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - P38 Inhibitor (4)
• Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement - This study is currently recruiting patients (Current: 23 Nov 2006)
• Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Patients With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - LY2127399,Methotrexate,Placebo
• Aralast alpha1-Proteinase Inhibitor Surveillance Study - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - ARALAST Fraction IV-1 Alpha1-Proteinase Inhibitor
• A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy - This study is currently recruiting patients (Current: 23 Nov 2006) - P38 Inhibitor (4)
• Open-Label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept - This study is no longer recruiting patients (Current: 23 Nov 2006) - infliximab,etanercept
• Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) - This study is currently recruiting patients (Current: 23 Nov 2006) - Tacrolimus ointment
• Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Bosentan (Tracleer)
• Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Open-Label Study With Bosentan in Interstitial Lung Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - bosentan
• Bosentan in Digital Ulcers - This study is no longer recruiting patients (Current: 23 Nov 2006) - bosentan
• FK506 Phase 4 Study: A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Tacrolimus
• SB-681323 In Subjects With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - SB-681323
• Pharmacogenomics of Anti-TNF Treatment in Patients With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department - This study is currently recruiting patients (Current: 23 Nov 2006) - Cefazolin and Moxifloxacin
• Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - prednisone - cyclosporine – methotrexate
• Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006)
• Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1) - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Oral R935788
• The Effects of a 16-Week Individualized, Intensive Strength Training Program in Patients With Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• ASAS Classification and Diagnostic Criteria for Early SpA - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Effects Of Prednisolone On Rheumatoid Arthritis Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement - This study is currently recruiting patients (Current: 23 Nov 2006) - mycophenolate mofetil
• Effectiveness of Radon Spa Therapy in Multimodal Rehabilitative Treatment of Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• Efficacy and Safety Study of GB-0998 for Treatment of Steroid-Resistant Polymyositis and Dermatomyositis (PM/DM) - This study is currently recruiting patients (Current: 23 Nov 2006) - High-dose intravenous immunoglobulin (Venoglobulin-IH)
• Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS - This study is currently recruiting patients (Current: 23 Nov 2006) - Anakinra
• Genetic Analysis of Patients With Pseudoxanthoma Elasticum - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Lupus Nephritis: Role of Environmental and Occupational Exposures - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Raptiva to Treat Sjogren's Syndrome - This study is currently recruiting patients (Current: 23 Nov 2006) - Raptiva
• A Phase II Study of Abatacept in Rheumatoid Arthritis in Japanese Patients With Active Rheumatoid Arthritis on-Responding to Methotrexate - This study is currently recruiting patients (Current: 23 Nov 2006) - Abatacept
• PRECISION : Prospective Randomized Evaluation of Celecoxib Integrated Safety vs Ibuprofen Or Naproxen - This study is currently recruiting patients (Current: 23 Nov 2006) - celecoxib,Ibuprofen,Naproxen
• An Open-Label Study to Assess the Rate of Failure of an Enbrel (Etanercept) SureClick Auto-Injector in Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
• Health Outcomes in Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Patient Experiences in Rheumatology - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis - This study is currently recruiting patients (Current: 23 Nov 2006) - High-dose intravenous immunoglobulin (Venoglobulin-IH)
• Yoga for Persons With Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome - This study is currently recruiting patients (Current: 23 Nov 2006) - rhIGF-1/rhIGFBP-3
• 16.0040 Ankylosing Spondylitis Study - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
• Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Atorvastatin
• Open-Label Extension Treatment With TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trial 016.0012 - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
• Open-Label Extension Treatment With TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trials - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept (TNFR:Fc)
• A Study of the Safety and Efficacy of Intravenous CNTO 148 (Golimumab) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy - This study is currently recruiting patients (Current: 23 Nov 2006) - Golimumab (CNTO 148) administered intravenously
• DCE-MRI Study (Dynamic Contrast-Enhanced Magnetic Resonance Imaging) - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Etanercept
• Rituximab Treatment in Sjogren's Syndrome - This study is currently recruiting patients (Current: 23 Nov 2006) - rituximab (anti-CD20)
• PSRand MFG-E8 Polymorphism in RA and SLE - This study is currently recruiting patients (Current: 23 Nov 2006)
• A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis. - This study is currently recruiting patients (Current: 23 Nov 2006) - tocilizumab
• Activity, Rheumatoid and Osteoarthritis, and Weight Management - This study has been completed (Current: 23 Nov 2006)
• Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. - This study is currently recruiting patients (Current: 23 Nov 2006) - PN 200 tablets (500 mg naproxen and 20 mg omeprazole),Naproxen 500 mg tablets (PN 200 minus omeprazole)
• The Effect of Eszopiclone 3 Mg Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Eszopiclone
• TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) - This study is currently recruiting patients (Current: 23 Nov 2006) - infliximab,azathioprine
• Phase IV PK, Safety/Tolerability Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase - This study is currently recruiting patients (Current: 23 Nov 2006) - large protein molecule
• Long-Term Assessment of Safety and Physical Function With AMG 108 in RA - This study is currently recruiting patients (Current: 23 Nov 2006) - AMG 108
• Evaluation of Safety, Efficacy, and Pharmacokinetics of 2 Oral Doses of PG-760564 in RA Patients Receiving Methotrexate. - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - PG-760564
• Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA) - This study has been completed (Current: 23 Nov 2006) - GW274150
• Low Dose Aspirin and Statins for Primary Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus: a Randomized Double-Blind Placebo-Controlled Trial - This study is currently recruiting patients (Current: 23 Nov 2006) - aspirin and rouvastatin
• The Use of Anti-CD4mAb-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Premature Coronary Atherosclerosis in Scleroderma, a Case Control Study - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Tylenol for Mood and Memory Changes Associated With Corticosteroid Therapy - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Acetaminophen
• Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Placebo Controlled Trial of Bosentan in Scleroderma Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - Bosentan
• A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis. - This study is no longer recruiting patients (Current: 23 Nov 2006) - mycophenolate mofetil [CellCept]
• Multi-Center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• APART Advanced Profiling of Anti-Rheumatic Therapies - This study is no longer recruiting patients (Current: 23 Nov 2006)
• A Study To Investigate The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - rosiglitazone XR
• A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. - This study is currently recruiting patients (Current: 23 Nov 2006) - GW274150,Prednisolone
• PhaseOpen-Label Study of MRA for Rheumatoid Arthritis(RA) - This study is currently recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
• A Safety and Pharmacokinetics Study in Patients With Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - LY2189102
• A Study for Patients Previously Enrolled in Study U2970g to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
• Study of Epratuzumab in Systemic Lupus Erythematosus - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Epratuzumab
• An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - PH-797804
• Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) - This study has been suspended (Current: 23 Nov 2006) - Epratuzumab

Drugs used in Clinical Trials for Connective tissue disorders

The format for each of the following is:

• The drug,
• followed by the name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Connective tissue disorders:

• 1% pimecrolimus cream - Treatment of Oral Erosive Lichen Planus With Pimecrolimus Cream - This study has been terminated (Current: 23 Nov 2006)
• 1) MOOV Head Lice Treatment (Ego Pharmaceutical). - A Randomised, Double Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides. - This study has been completed (Current: 23 Nov 2006)
• 111In-DAC - Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• 131I-TM-601 - 131I-TM-601 Study in Adults With Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• 15-O labeled water - Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients - This study has been completed (Current: 23 Nov 2006)
• 17-N-allylamino-17-demethoxygeldanamycin - 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• 17-N-allylamino-17-demethoxygeldanamycin - 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• 17-N-allylamino-17-demethoxygeldanamycin - 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Stage III or Stage IV Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• 17-dimethylaminoethylamino-17-demethoxygeldanamycin - 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• 2-deoxy-2 [F-18] fluoro-2-d-glucose - Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity - This study has been completed (Current: 23 Nov 2006)
• 2-deoxy-D-glucose (2DG) - Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• 3) KP24 Medicated Foam (Nelson Laboratories) - A Randomised, Double Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides. - This study has been completed (Current: 23 Nov 2006)
• 3-AP - 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• 4 Phenyl Butyrate (4PBA) - 4-PBA: Will It Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency? - This study is no longer recruiting patients (Current: 23 Nov 2006)
• 4-hydroxytamoxifen - Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women - This study has been completed (Current: 23 Nov 2006)
• 5-Fluorouracil - Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• 5-Fluorouracil - Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• 5-fluoro-2-deoxycytidine - 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Advanced Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• 5-fluorouracil - A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• 5-fluorouracil - ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment - This study is currently recruiting patients (Current: 23 Nov 2006)
• 5-fluorouracil - Evaluation of Differing Taxanes/Taxane Combinations on the Outcomes of Patients With Operable Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• 5-fluorouracil - Safety of DAVANAT With and Without 5-Fluorouracil in Patients With Solid Tumors - This study has been completed (Current: 23 Nov 2006)
• 500 mg twice-daily oral valacyclovir - HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 co-Infected Men. - This study has been completed (Current: 23 Nov 2006)
• 5FU - Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers - This study is currently recruiting patients (Current: 23 Nov 2006)
• 7-hydroxystaurosporine (UCN-01) - A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms - This study has been completed (Current: 23 Nov 2006)
• 852A - 852A in Treating Patients With Refractory Metastatic Breast Cancer, Ovarian Cancer, Endometrial Cancer, or Cervical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• 852A - Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers - This study is currently recruiting patients (Current: 23 Nov 2006)
• 9-cis-Retinoic Acid - A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients - This study has been completed (Current: 23 Nov 2006)
• A Combination Of Probiotics - Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics. - This study is currently recruiting patients (Current: 23 Nov 2006)
• ABI-007 (Abraxane) and Bevacizumab - A Phase II Study of Weekly Versus Every 2-Week Versus Every 3-Week Administration of ABI-007 (Abraxane) in Combination With Bevacizumab in Women With Metastatic Breast Cancer. - This study is currently recruiting patients (Current: 23 Nov 2006)
• ABI-007 and Taxotere - Phase II Trial Comparing ABI-007 to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• ABI-007 - ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• ABI-007 - ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• ABI-007 - ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• ABI-007 - Neo-Adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• ABI-007 - Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• ABI-007 - Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• ABI-007 - Study of ABI-007 in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• ABI-007 - Study of Dose-Dense Adriamycin Plus Cytoxan (AC) Followed by Either Abraxane or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• ABI-007; Vinorelbine; G-CSF (Granulocyte- Colony Stimulating Factor) - An Open-Label Phase I Study of Weekly ABI-007 and Vinorelbine With or Without G-CSF in Patients With Stage IV (Metastatic) Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• ABT-751 - A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. - This study is no longer recruiting patients (Current: 23 Nov 2006)
• ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM) - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
• ACZONE (dapsone) Gel, 5%, 1x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
• ACZONE (dapsone) Gel, 5%, 2x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
• ACZONE Gel, 5% - Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency. - This study has been completed (Current: 23 Nov 2006)
• AD 452 - A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects. - This study is no longer recruiting patients (Current: 23 Nov 2006)
• AFP464 - AFP464 in Treating Patients With Advanced Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• ALIMTA plus Epirubicin - Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• ALIMTA - ALIMTA (Pemetrexed) as First Line Chemotherapy for Advanced Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• ALVAC-CEA vaccine - Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• ALVAC-hB7.1/canarypox-hIL-12 melanoma vaccine - Vaccine Therapy in Treating Patients With Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• ALVAC-hB7.1 - Vaccine Therapy in Treating Patients With Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• AMG 108 - A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• AMG 108 - Long-Term Assessment of Safety and Physical Function With AMG 108 in RA - This study is currently recruiting patients (Current: 23 Nov 2006)
• AMG 162 - AMG 162 in Biphosphonate Naive Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• AMG 162 - AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• AMG 162 - Efficacy, Safety and Tolerability of AMG 162 in the Treatment of Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• AMG 706 - A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• AMG 706 - Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Subjects With Advanced Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• AMG 719 - A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate - This study has been terminated (Current: 23 Nov 2006)
• ARALAST Fraction IV-1 Alpha1-Proteinase Inhibitor (ARALAST Fr. IV-1) - Efficacy and Safety Study of Augmentation Therapy With Aralast (Human Alpha 1 - Proteinase Inhibitor) - This study is currently recruiting patients (Current: 23 Nov 2006)
• ARALAST Fraction IV-1 Alpha1-Proteinase Inhibitor (ARALAST Fr. IV-1) - Pharmacokinetic Study of Aralast (Human Alpha1- PI) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• ARALAST Fraction IV-1 Alpha1-Proteinase Inhibitor - Aralast alpha1-Proteinase Inhibitor Surveillance Study - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• ARIMIDEX (anastrazole) - PROACT - Pre-Operative Arimidex Compared To Tamoxifen - This study is no longer recruiting patients (Current: 23 Nov 2006)
• ATG002 (study drug) - Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• ATG - Stem Cell Transplant for Inborn Errors of Metabolism - This study is currently recruiting patients (Current: 23 Nov 2006)
• ATG - Stem Cell Transplantation for Hurler - This study is currently recruiting patients (Current: 23 Nov 2006)
• ATRA plus G-CSF (filgrastim, NEUPOGEN (R)) combination - ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells - This study has been completed (Current: 23 Nov 2006)
• AZD2171 - AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• AZD2171 - AZD2171 in Breast Cancer Stage IV - This study is currently recruiting patients (Current: 23 Nov 2006)
• AZD2171 - AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• AZD2171 - AZD2171 in Treating Patients With Refractory Stage IV Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abacavir sulfate, Lamivudine and Zidovudine - Changing to Nonprotease Inhibitor Treatment to Improve Side Effects - This study has been completed (Current: 23 Nov 2006)
• Abacavir sulfate - A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients - This study has been completed (Current: 23 Nov 2006)
• Abacavir sulfate - Changing to Nonprotease Inhibitor Treatment to Improve Side Effects - This study has been completed (Current: 23 Nov 2006)
• Abacavir sulfate - Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Abacavir - HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abatacept or Infliximab with Methotrexate - Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Abatacept, Prednisone or Prednisone equivalent - Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abatacept - A Phase II Study of Abatacept in Rheumatoid Arthritis in Japanese Patients With Active Rheumatoid Arthritis on-Responding to Methotrexate - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abatacept - A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris - This study has been completed (Current: 23 Nov 2006)
• Abatacept - An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Abatacept - BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Abatacept - CTLA4IG With Methotrexate- Phase IIB - Long Term - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Abatacept - Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Abatacept - Phase I/II Multiple-Dose LEA29Y Vs CTLAG4Ig Vs Placebo in Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• Abatacept - Remission in Early Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abatacept - Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-Biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abatacept - Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Abatacept - Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abatacept - The Study of Abatacept in Combination With Etanercept - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Abatacept - Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers - This study has been completed (Current: 23 Nov 2006)
• Abetimus Sodium (Ljp 394) - Study of LJP 394 (Abetimus Sodium) in Lupus Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abetimus Sodium (Ljp 394) - Study of LJP 394 in Lupus Patients With History of Renal Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abetimus sodium (LJP 394) - Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease - This study has been completed (Current: 23 Nov 2006)
• Abraxane - Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Abraxane - Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Acetaminophen, Acetaminophen Plus Codeine, Ibuprofen - T3AI-Pain After Breast Surgery - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Acetaminophen - Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Acetaminophen - Tylenol for Mood and Memory Changes Associated With Corticosteroid Therapy - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Acetylcysteine - Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Acitretin - Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Acitretin - Acitretin in Treating Patients With Skin Disease or Skin Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Acitretin - Treatment of Psoriasis Using Acitretin in HIV-Positive Patients - This study has been completed (Current: 23 Nov 2006)
• Acyclovir - A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients - This study has been completed (Current: 23 Nov 2006)
• Acyclovir - A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients - This study has been completed (Current: 23 Nov 2006)
• Acyclovir - Acyclovir HSV Skin, Eye, and Mouth - This study is currently recruiting patients (Current: 23 Nov 2006)
• Acyclovir - Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates - This study is currently recruiting patients (Current: 23 Nov 2006)
• Acyclovir - Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir - This study has been completed (Current: 23 Nov 2006)
• Acyclovir - Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS) - This study has been completed (Current: 23 Nov 2006)
• Acyclovir - Episodic Acyclovir Therapy for Genital Ulcers - This study is currently recruiting patients (Current: 23 Nov 2006)
• Acyclovir - Herpetic Eye Disease Study (HEDS) II - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Acyclovir - Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection - This study has been completed (Current: 23 Nov 2006)
• Acyclovir - Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System - This study is currently recruiting patients (Current: 23 Nov 2006)
• Acyclovir - Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth - This study has been completed (Current: 23 Nov 2006)
• Acyclovir - Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth - This study has been completed (Current: 23 Nov 2006)
• Acyclovir - The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood - This study has been completed (Current: 23 Nov 2006)
• Ad5CMV-p53 gene - Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• Adalimumab (D2E7) - Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab (D2E7) - Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• Adalimumab (Up To 5 Years Exposure) - Long Term Open Label Continuation Study - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab (Up To 9 Months Exposure) - Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adalimumab 40 mg sc every other week - D2E7-Early AS - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab/anti-TNF alfa - Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - A Long Term Roll-Over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-Term to Patients With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Adalimumab in Combination With Methotrexate Vs Methotrexate Alone in Early Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Efficacy, Safety, Immunogenicity and Effect on Immune Response of Adalimumab Following Subcutaneous Administration in Patients With Active RA Treated Concomitantly With MTX. - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Adalimumab - Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Post-Marketing Observational Study in Subjects With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Quality of Life Study With Adalimumab in Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adalimumab - Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adalimumab - TNFalfa Blocking Treatment of Spondylarthropathies - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adenovirus P53 - Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• Adenovirus Rsv-Tk - Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma - This study has been completed (Current: 23 Nov 2006)
• Adenovirus-Mediated Human Interleukin-12 - Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adjuvant capecitabine - Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study - This study is currently recruiting patients (Current: 23 Nov 2006)
• Administration of ivermectin or permethrin - Comparison of the Efficacy and Safety of Ivermectin to Permethrin - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adriamycin/Cytoxan - Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Adriamycin/cytoxan - Biologic Correlative Taxotere/AC - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adriamycin - Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Adriamycin - Study of Dose-Dense Adriamycin Plus Cytoxan (AC) Followed by Either Abraxane or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Advantan - Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aerosolized, Recombinant Alpha 1-Antitrypsin - Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency - This study has been completed (Current: 23 Nov 2006)
• Aerosolized, Recombinant Alpha 1-Antitrypsin - Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency - This study has been completed (Current: 23 Nov 2006)
• Albendazole Vs. Combined Albendazole/Ivermectin Treatment - Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections - This study has been completed (Current: 23 Nov 2006)
• Aldara (imiquimod 5% cream) - Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream - This study has been completed (Current: 23 Nov 2006)
• Aldara (imiquimod) cream, 5% - Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Aldara Cream 5% - Aldara for the Treatment of Extensive Alopecia Areata - This study has been completed (Current: 23 Nov 2006)
• Aldara Cream 5% - Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% - This study has been completed (Current: 23 Nov 2006)
• Aldesleukin - Adesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Aldesleukin in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Aldesleukin - Biological Therapy in Treating Women With Stage IV Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung - This study has been completed (Current: 23 Nov 2006)
• Aldesleukin - Chemotherapy Consisting of Fludarabine and Cyclophosphamide Followed By White Blood Cell Infusion, Vaccine Therapy, and Interleukin-2 in Treating Patients With Recurrent or Refractory Metastatic Melanoma - This study has been suspended (Current: 23 Nov 2006)
• Aldesleukin - Chemotherapy Followed By Autologous Natural Killer Cells and Aldesleukin in Treating Patients With Metastatic Melanoma or Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer or Other Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Chemotherapy and Total-Body Irradiation Followed By Autologous Lymphocyte Infusion, Aldesleukin, and Autologous Stem Cell Transplant in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Cyclophosphamide and Fludarabine Followed By White Blood Cell Infusion and High-Dose Aldesleukin in Treating Patients With Metastatic Cancer That Overexpresses p53 - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Interleukin-2 in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Donor Peripheral Stem Cell Transplant After Fludarabine and Cyclophosphamide in Treating Patients With Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldesleukin - Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aldurazyme (Recombinant Human Alpha-L-Iduronidase) - A Dose-Optimization Study of Aldurazyme (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Aldurazyme (Recombinant Human Alpha-L-Iduronidase) - Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Alefacept - Alefacept in Patients With Severe Scalp Alopecia Areata - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alefacept - Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alefacept - Safety and Tolerability of Repeat Courses of IM Alefacept - This study has been completed (Current: 23 Nov 2006)
• Alefacept - Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alemtuzumab - Alemtuzumab, Tacrolimus, and Methylprednisolone in Treating Acute Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alemtuzumab - Peripheral Stem Cell Transplant Plus Monoclonal Antibody Therapy in Treating Patients With High-Risk Hematologic Cancer, Refractory Breast or Kidney Cancer, or Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alendronate Sodium - Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27 - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alendronate Sodium - Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Alendronate sodium - Bisphosphonate and Anastrozole Trial Bone Maintenance Algorithm Assessment - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alendronate versus alfacalcidol (1-alpha OH vitamin D) - Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. - This study has been completed (Current: 23 Nov 2006)
• Alendronate - Alendronate Osteoporosis Study - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Alendronate - Bisphosphonate Therapy for Osteogenesis Imperfecta - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alendronate - Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alitretinoin - Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Alitretinoin - Follow-Up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alitretinoin - Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Gm-Csf-Secreting Breast Cancer Vaccine - Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Gm-Csf-Secreting Breast Cancer Vaccine - Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Gm-Csf-Secreting Breast Cancer Vaccine - Vaccine Therapy, Interferon Alfa, and Cyclophosphamide in Treating Women With Stage IV Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Lymphocytes - Allogeneic Peripheral Stem Cell Transplant After Antithymocyte Globulin, High-Dose Melphalan, and Fludarabine in Treating Women With Metastatic Adenocarcinoma of the Breast - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Lymphocytes - Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Allogeneic Lymphocytes - Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Allogeneic Lymphocytes - Chemotherapy, Radiation Therapy, Peripheral Stem Cell Transplantation, and Immunosuppressive Therapy in Treating Patients With Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Allogeneic Lymphocytes - Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Donor Lymphocyte Infusion in Treating Women With Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Allogeneic Lymphocytes - Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma - This study has been completed (Current: 23 Nov 2006)
• Allogeneic Lymphocytes - Donor Peripheral Stem Cell Transplant After Fludarabine and Cyclophosphamide in Treating Patients With Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Lymphocytes - Monoclonal Antibody Therapy After Allogeneic Stem Cell Transplantation in Treating Patients With Persistent or Progressive Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Lymphocytes - Pentostatin and Donor White Blood Cells in Preventing Graft Rejection in Cancer Patients Who Have Undergone Donor Stem Cell Transplantation - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allogeneic Tumor Cell Vaccine - Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Allopurinol - Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil - This study has been completed (Current: 23 Nov 2006)
• Allovectin-7/Dacarbazine - Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Allovectin-7 - Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Allovectin-7 - Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Alpha-1 Proteinase Inhibitor (Human) - The Comparison of the Pharmacokinetic, Safety and Tolerability of Alpha-1 MP and Prolastin in Adult alpha1-Antitrypsin Deficient Patients. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alpha-1 Proteinase Inhibitor (Human) - The Safety and Tolerability of Alpha-1 MP in Subjects With Alpha-1-Antitrypsin (AAT) Deficiency. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alpha-1-Proteinase Inhibitor (Human) - Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Alpha-Tocopherol - The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alpha-Type-1 Polarized Dendritic Cells - Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Alum Adjuvant - Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Amevive (Alefacept) - A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus - This study has been suspended (Current: 23 Nov 2006)
• Amifostine Trihydrate - Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Amifostine - Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Amifostine - Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Amifostine - High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation and Chemoprotective Therapy in Treating Patients With Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Amifostine - High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Aminolevulinic Acid - Photodynamic Therapy in Treating Patients With Skin Cancer - This study has been suspended (Current: 23 Nov 2006)
• Amonafide - Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy - This study has been completed (Current: 23 Nov 2006)
• Amoxicillin-Clavulante - Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Amphotericin B Liposomal - Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Amphotericin B Liposomal - Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Amphotericin B - A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis - This study has been completed (Current: 23 Nov 2006)
• Ampicillin-Sulbactam - Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Ampicillin/Sulbactam - The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Amprenavir - HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Amrubicin - Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Anakinra (Kineret®) - Anakinra (Kineret) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA) - This study has been completed (Current: 23 Nov 2006)
• Anakinra (r-metHuIL-1ra) - Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA) - This study has been completed (Current: 23 Nov 2006)
• Anakinra - Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anakinra - Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anakinra - Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anakinra - Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• Anastrazole - Anti-Tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrazole - Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study - This study has been completed (Current: 23 Nov 2006)
• Anastrozole (ARIMIDEX™) - Open Label Arimidex in Gynecomastia - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole (Arimidex) - Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole 1 mg - Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole and goserelin - Study on Pre-Menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - A Randomized, Double-Blind, Controlled Study in Postmenopausal Women With Advanced/Recurrent Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - ARNO-95 - Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Adjuvant Treatment in Patients With Hormone Receptor-Positive Breast Cancer With Good to Moderate Differentiation. - This study has been completed (Current: 23 Nov 2006)
• Anastrozole - Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Anastrozole With or Without Lonafarnib in Treating Postmenopausal Women With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• Anastrozole - Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Arimidex Neoadjuvant in Operable Breast Cancer in Post-Menopausal Women - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• Anastrozole - Clinical Study Comparing ARIMIDEX With NOLVADEX in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Combination Chemotherapy and Surgery in Treating Patients With Stage II or Stage III Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Docetaxel, Epirubicin, Cyclophosphamide, Trastuzumab, and Radiation Therapy in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 - This study has been completed (Current: 23 Nov 2006)
• Anastrozole - Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Secondary Adjuvant Long Term Study With Arimidex - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Simvastatin and Anastrozole in Treating Postmenopausal Women With Invasive Breast Cancer, Ductal Carcinoma In Situ, or a High Risk of Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anastrozole - Trial Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Annamycin Liposomal - Chemotherapy in Treating Patients With Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• Anti IL-12 monoclonal antibody/ABT-874/up to 12 weeks - Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody - Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery - This study has been suspended (Current: 23 Nov 2006)
• Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody - Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma - This study has been completed (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Allogeneic Peripheral Stem Cell Transplant After Antithymocyte Globulin, High-Dose Melphalan, and Fludarabine in Treating Women With Metastatic Adenocarcinoma of the Breast - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Combination Chemotherapy and Radiation Therapy Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Comparison of Antibody Therapies in Treating Patients With Graft- Versus-Host Disease That Does Not Respond to Steroid Therapy - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Phase II Study of Allogeneic Bone Marrow or Umbilical Cord Blood Transplantation in Patients With Mucopolysaccharidosis I (Hurler Disease) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-Thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders - This study is currently recruiting patients (Current: 23 Nov 2006)
• Anti-Thymocyte Globulin - Study of High-Dose Cyclophosphamide and Anti-Thymocyte Globulin With T-Cell-Depleted Autologous Bone Marrow Rescue in Patients With High-Risk Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Anti-Tumor Necrosis Factor - Blocking Tumor Necrosis Factor in Ankylosing Spondylitis - This study has been completed (Current: 23 Nov 2006)
• Antimicrobial Agent In Soap - Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area - This study has been completed (Current: 23 Nov 2006)
• Antimony - Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Stage IV Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Women With Advanced Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antineoplaston A10 - Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Stage IV Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Women With Advanced Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Antineoplaston As2-1 - Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Antracycline - Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) Vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• Application of pimecrolimus - Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris - This study has been completed (Current: 23 Nov 2006)
• Aprepitant - Aprepitant, Granisetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Cyclophosphamide Before a Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aprepitant - Aprepitant, Ondansetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aprotinin - Phase I Study of Aprotinin in Advanced Breast Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Aquaphor - Topical Therapy for Prevention of Infections in Preterm Infants - This study has been completed (Current: 23 Nov 2006)
• Arginine Butyrate - Phase II Randomized Trial of Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers - This study is currently recruiting patients (Current: 23 Nov 2006)
• Arimidex - Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aromasin - Randomized Phase III Study of Exemestane (Aromasin) for 5 Years vs. Tamoxifen for 2.5 - 3 Years Followed by Exemestane - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Aromatase Inhibition - Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Aromatase Inhibition - Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Aromatase Inhibition - Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• Aromatase Inhibition - Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Aromatase inhibition - The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Arsenic Trioxide - Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Arthroscopic Biopsy - Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Arzoxifene Hydrochloride - Arzoxifene and Tamoxifen in Preventing Breast Cancer in Women at High Risk for Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• Arzoxifene - A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Aspirin And Rouvastatin - Low Dose Aspirin and Statins for Primary Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus: a Randomized Double-Blind Placebo-Controlled Trial - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aspirin - A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Aspirin - Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Aspirin - Prevention of Coronary Aneurysms in Kawasaki Syndrome - This study has been completed (Current: 23 Nov 2006)
• Atamestane - Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Atamestane - The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Atamestane - Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Atamestane - Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Atazanavir/Ritonavir - Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Atazanavir - Study of Reyataz in HIV-Infected Patients With Lipodystrophy Syndrome - This study is currently recruiting patients (Current: 23 Nov 2006)
• Atorvastatin (10 mg or 80 mg) - Improving Diabetic Foot Ulcers With Atorvastatin - This study is currently recruiting patients (Current: 23 Nov 2006)
• Atorvastatin calcium - The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs - This study has been completed (Current: 23 Nov 2006)
• Atorvastatin - Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Atorvastatin - Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Atorvastatin - Lupus Atherosclerosis Prevention Study - This study has been completed (Current: 23 Nov 2006)
• Autologous Dendritic Cell-Adenovirus P53 Vaccine - Vaccine Therapy With Either Neoadjuvant or Adjuvant Chemotherapy and Adjuvant Radiation Therapy in Treating Women With p53-Overexpressing Stage II or Stage III Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine - Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Autologous Dendritic Cells - Biological Therapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Dendritic Cells - Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Dendritic Cells - Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer - This study has been completed (Current: 23 Nov 2006)
• Autologous Dendritic Cells - Vaccine Therapy in Treating Patients With Metastatic Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Dendritic Cells - Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma - This study has been completed (Current: 23 Nov 2006)
• Autologous Dendritic Cells - Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Dendritic Cells - Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Autologous Lymphocytes - Biological Therapy in Treating Patients With Metastatic Melanoma - This study has been suspended (Current: 23 Nov 2006)
• Autologous Lymphocytes - Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic Melanoma - This study has been completed (Current: 23 Nov 2006)
• Autologous Lymphocytes - Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma - This study has been suspended (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma - This study has been completed (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Vaccine Therapy in Treating Patients With Stage IIIC or Stage IV Malignant Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Vaccine Therapy in Treating Patients With Stage IV Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Autologous Tumor Cell Vaccine - Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Avandia administration for 6-12 weeks - Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome - This study has been completed (Current: 23 Nov 2006)
• Avastin (bevacizumab) - A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study - This study has been completed (Current: 23 Nov 2006)
• Azacitidine - Azacitidine and Interferon Alfa-2b in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Azacitidine - Azacitidine and Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
• Azathioprine (active comparator, maintenance) - Aspreva Lupus Management Study (ALMS) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Azathioprine - CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Azathioprine - Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Azathioprine - Scleroderma Lung Study - This study has been completed (Current: 23 Nov 2006)
• Azathioprine - TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Azelaic Acid - Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne. - This study has been completed (Current: 23 Nov 2006)
• Azithromycin microspheres - Phase III Double-Blind Double Dummy Study On Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• BAY 43-9006, A Raf Kinase Inhibitor - BAY43-9006 - Phase II in Advance Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BCG - Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BCG - Vaccine Therapy in Treating Women With Metastatic Breast Cancer - This study has been completed (Current: 23 Nov 2006)
• BCX-1777 - BCX-1777 in Treating Patients With Refractory Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BG9924 - Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006)
• BMS-188667 - A Phase III Study of BMS-188667 in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BMS-188667 - A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• BMS-188667 - Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. - This study has been completed (Current: 23 Nov 2006)
• BMS-247550 - BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BMS-247550 - BMS-247550 in Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer - This study has been completed (Current: 23 Nov 2006)
• BMS-247550 - BMS-247550 in Treating Patients With Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BMS-247550 - BMS-247550 in Treating Women With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BMS-247550 - Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• BMS-275291 - A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy - This study has been suspended (Current: 23 Nov 2006)
• BMS-582949 and Methotrexate - Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background - This study is currently recruiting patients (Current: 23 Nov 2006)
• BMS-582949 - A Phase IIa Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• BNP7787 - Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bacitracin (Allergen) - Clinical Evaluation of Bacitracin - This study has been completed (Current: 23 Nov 2006)
• Bacitracin zinc/Polymyxin B sulfate - Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine - This study has been completed (Current: 23 Nov 2006)
• Banlice Mousse Aerosol (Pfizer, Australia) - A Randomised, Double Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides. - This study has been completed (Current: 23 Nov 2006)
• Bay 59-8862 - Evaluation of Bay 59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients - This study has been completed (Current: 23 Nov 2006)
• Becaplermin - A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Beclomethasone - Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Belatacept - Phase I/II Multiple-Dose LEA29Y Vs CTLAG4Ig Vs Placebo in Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
• Belimumab (Lymphostat-B) - Study of LymphoStat-B (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Belimumab (Lymphostat-B) - Study of LymphoStat-B in Subjects With Systemic Lupus Erythematosus (SLE) - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bemiparin (Low Molecular Weight Heparin) - Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients - This study has been terminated (Current: 23 Nov 2006)
• Benefin - Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab (drug), Herceptin (drug) - Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab (drug) - Therapy With Bevacizumab (BEV), Doxorubicin,and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab Combined With Dose Dense Chemotherapy - Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab Plus Paclitaxel - A Phase 3 Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Bevacizumab [Avastin] - A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab [Avastin] - A Study of Avastin (Bevacizumab) in Women With HER2 Negative Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - A Phase II Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab as First Line Therapy for Locally Recurrent or Metastatic Breast Cancer (MBC) - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Bevacizumab - A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - A Trial of Taxol and Bevacizumab vs. Gemcitabine, Taxol, and Bevacizumab in Advanced Breast Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Bevacizumab - ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab Plus Docetaxel and Doxorubicin in Treating Patients With Previously Untreated Inflammatory or Locally Advanced Stage IIB or Stage III Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab and Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Bevacizumab and Trastuzumab (Herceptin) in Treating Women With Relapsed or Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Chemotherapy With or Without Monoclonal Antibody in Treating Women With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Chemotherapy and Bevacizumab in Treating Women With High-Risk Invasive Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Docetaxel With or Without Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Letrozole in Combination With Bevacizumab in Patients With ER and/or PR Positive Patients With Advanced Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Neoadjuvant Treatment of Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Pilot Study of Docetaxel and Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Pilot Study of Safety and Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab +/- Trastuzumab for Adjuvant Treatment of Patients With Node-Positive and High-Risk Node-Negative Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Study of Dose-Dense Adriamycin Plus Cytoxan (AC) Followed by Either Abraxane or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Taxotere Plus Bevacizumab (AVF3110) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Bevacizumab - The Study of Avastin to Reverse AEI in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bevacizumab - Vorinostat, Paclitaxel, and Bevacizumab in Treating Patients With Metastatic Breast Cancer and/or Breast Cancer That Has Recurred in the Chest Wall and Cannot be Removed by Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bexarotene 1% gel - Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis - This study has been terminated (Current: 23 Nov 2006)
• Bexarotene/NBUVB vs placebo NBUVB - Bexarotene With Narrow-Band UVB for Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bexarotene - Bexarotene in Preventing Breast Cancer in Women at Genetic Risk - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bexarotene - Bexarotene in Treating Patients With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bifidobacterium longum - Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-Up to 5 Years - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bifidobacterium longum - Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bimatoprost (Lumigan) - Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Biologic Therapy - A Study of Infliximab (Remicade) in Subjects With Giant Cell Arteritis - This study has been completed (Current: 23 Nov 2006)
• Biologics - Predictors of the Response to Etanercept and Adalimumab in Rheumatoid Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Black Cohosh - Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bleomycin - Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bone Marrow Ablation With Stem Cell Support - Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bone Marrow Ablation With Stem Cell Support - Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bone Marrow Ablation With Stem Cell Support - Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bone Marrow Ablation With Stem Cell Support - Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bone Marrow Ablation With Stem Cell Support - Repeated Bone Marrow Transplantation in Treating Patients With Advanced Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Borage Seed Oil - Treatment of Rheumatoid Arthritis With Marine and Botanical Oils - This study is currently recruiting patients (Current: 23 Nov 2006)
• Boronophenylalanine-Fructose Complex - Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Boronophenylalanine-Fructose Complex - Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Borophenylalanine-Fructose Complex - Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bortezomib - Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bortezomib - PS-341 in Treating Women With Metastatic Breast Cancer - This study has been suspended (Current: 23 Nov 2006)
• Bortezomib - PS-341 in Treating Women With Metastatic Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bosentan (Tracleer) - Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Bosentan - Bosentan in Digital Ulcers - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bosentan - Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bosentan - Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients - This study has been completed (Current: 23 Nov 2006)
• Bosentan - Open-Label Study With Bosentan in Interstitial Lung Disease - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bosentan - Placebo Controlled Trial of Bosentan in Scleroderma Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bosentan - Treatment of Early Systemic Sclerosis by Bosentan - This study is currently recruiting patients (Current: 23 Nov 2006)
• Botulinum Toxin Type A - A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis - This study is currently recruiting patients (Current: 23 Nov 2006)
• Botulinum Toxin Type A - A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Botulinum Toxin Type A - A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Botulinum Toxin Type A - Study of Botulinum Toxin in Patients With Primary Hyperhidrosis - This study has been completed (Current: 23 Nov 2006)
• Bovine type I collagen - Oral Type I Collagen for Relieving Scleroderma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bovine type II collagen - Oral Collagen for Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Breast Imaging Studies - MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bryostatin 1 - Bryostatin 1 in Treating Patients With Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Bryostatin 1 - Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer - This study has been suspended (Current: 23 Nov 2006)
• Bryostatin 1 - Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Bupropion Extended Release (Wellbutrin Xl) - Wellbutrin XL, Major Depressive Disorder and Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
• Busulfan - Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer or Other Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Busulfan - Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Busulfan - Combination Chemotherapy and Peripheral Stem Cell Transplantation Followed by Interleukin-2 and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Busulfan - Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
• Busulfan - High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
• Busulfan - Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery - This study has been completed (Current: 23 Nov 2006)
• Busulfan - Phase II Study of Allogeneic Bone Marrow or Umbilical Cord Blood Transplantation in Patients With Mucopolysaccharidosis I (Hurler Disease) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Busulfan - Stem Cell Transplant for Inborn Errors of Metabolism - This study is currently recruiting patients (Current: 23 Nov 2006)
• Busulfan - Stem Cell Transplantation for Hurler - This study is currently recruiting patients (Current: 23 Nov 2006)
• C1 Esterase Inhibitor - C1 Esterase Inhibitor in HAE (Extension Study) - This study is currently recruiting patients (Current: 23 Nov 2006)
• C1 Esterase Inhibitor - Human C1 Esterase Inhibitor in Subjects With Congenital C1-INH Deficiency and Acute Abdominal and Facial HAE Attacks - This study is currently recruiting patients (Current: 23 Nov 2006)
• C1 esterase inhibitor (human) - Safety and Efficacy Study of C1 Esterase Inhibitor (Human) for the Treatment of Hereditary Angioedema (HAE) in Acute Attacks and as Prophylactic Treatment to Prevent HAE Attacks - This study is currently recruiting patients (Current: 23 Nov 2006)
• C1 inhibitor concentrate (C1-esteraseremmer-N) - C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema - This study is not yet open for patient recruitment (Current: 23 Nov 2006)

The trial data on this page has been sourced from

• The U.S. National Library of Medicine (NLM) together with ClinicalTrials.gov

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

• Surveys relating to Connective tissue disorders
• Ask Question about Connective tissue disorders

Tools & Services:

• Bookmark this page
• Take a survey relating to Connective tissue disorders
• Symptom Search
• Symptom Checker
• Medical Dictionary
• Give your feedback

Medical Articles:

• Disease & Treatments Search
• Misdiagnosis Center
• Full list of interesting articles

Forums & Message Boards

• Ask or answer a question at the Boards:
• I cannot get a diagnosis. Please help.
• Tell us your medical story.
• Share your misdiagnosis story.
• What is the best treatment for my condition?
• See all the Boards.

Enter your search terms Submit search form
Search The Web Search wrongdiagnosis.com

Common Health Mistakes

Symptom
Checker

Search Specialists by State and City